Jeevan Scientific Technology Ltd
BSE:538837
Jeevan Scientific Technology Ltd
BSE:538837
Price:
75.95
INR
2.51%
Market Cap:
₹1.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Jeevan Scientific Technology Ltd
BSE:538837
|
IN |
|
C
|
Central Plains Bancshares Inc
NASDAQ:CPBI
|
US |
Balance Sheet
Balance Sheet Decomposition
Jeevan Scientific Technology Ltd
Jeevan Scientific Technology Ltd
Balance Sheet Decomposition is not available for
Jeevan Scientific Technology Ltd
Jeevan Scientific Technology Ltd
Balance Sheet
Jeevan Scientific Technology Ltd
Jeevan Scientific Technology Ltd
Currency: INR
| Mar-2012 | Mar-2013 | Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
1
|
1
|
2
|
3
|
14
|
37
|
22
|
62
|
298
|
|
| Cash |
0
|
0
|
0
|
0
|
1
|
1
|
7
|
1
|
1
|
30
|
284
|
|
| Cash Equivalents |
0
|
0
|
1
|
1
|
1
|
1
|
7
|
36
|
21
|
33
|
13
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
2
|
3
|
11
|
18
|
23
|
78
|
|
| Total Receivables |
47
|
39
|
25
|
73
|
80
|
129
|
185
|
154
|
119
|
199
|
144
|
|
| Accounts Receivables |
47
|
39
|
25
|
73
|
72
|
113
|
161
|
147
|
68
|
144
|
76
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
8
|
16
|
24
|
7
|
51
|
55
|
68
|
|
| Inventory |
1
|
1
|
22
|
23
|
1
|
5
|
1
|
2
|
9
|
35
|
15
|
|
| Other Current Assets |
2
|
2
|
3
|
6
|
4
|
1
|
2
|
44
|
12
|
20
|
5
|
|
| Total Current Assets |
50
|
41
|
51
|
102
|
88
|
140
|
204
|
249
|
181
|
339
|
539
|
|
| PP&E Net |
18
|
15
|
13
|
57
|
82
|
106
|
180
|
196
|
177
|
159
|
141
|
|
| Intangible Assets |
1
|
2
|
1
|
1
|
5
|
57
|
58
|
130
|
128
|
115
|
50
|
|
| Note Receivable |
15
|
15
|
9
|
5
|
0
|
5
|
40
|
38
|
37
|
41
|
49
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
10
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
5
|
5
|
5
|
5
|
2
|
1
|
0
|
0
|
16
|
6
|
0
|
|
| Total Assets |
88
N/A
|
78
-12%
|
79
+2%
|
170
+115%
|
182
+7%
|
309
+70%
|
493
+60%
|
613
+24%
|
539
-12%
|
660
+22%
|
779
+18%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
4
|
4
|
7
|
51
|
33
|
22
|
21
|
24
|
25
|
33
|
20
|
|
| Short-Term Debt |
32
|
42
|
41
|
22
|
24
|
25
|
70
|
73
|
74
|
1
|
52
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
3
|
12
|
51
|
70
|
27
|
25
|
29
|
|
| Other Current Liabilities |
4
|
8
|
3
|
5
|
22
|
32
|
23
|
47
|
100
|
170
|
120
|
|
| Total Current Liabilities |
40
|
54
|
51
|
77
|
83
|
92
|
165
|
214
|
225
|
229
|
221
|
|
| Long-Term Debt |
5
|
3
|
1
|
41
|
83
|
47
|
98
|
75
|
79
|
78
|
44
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
4
|
0
|
0
|
5
|
|
| Other Liabilities |
0
|
0
|
3
|
13
|
0
|
1
|
1
|
2
|
3
|
3
|
3
|
|
| Total Liabilities |
45
N/A
|
56
+25%
|
55
-2%
|
132
+138%
|
166
+26%
|
140
-16%
|
266
+90%
|
295
+11%
|
307
+4%
|
310
+1%
|
273
-12%
|
|
| Equity | ||||||||||||
| Common Stock |
60
|
60
|
60
|
60
|
60
|
93
|
115
|
153
|
153
|
153
|
153
|
|
| Retained Earnings |
17
|
39
|
37
|
23
|
45
|
76
|
112
|
165
|
79
|
197
|
353
|
|
| Total Equity |
43
N/A
|
21
-51%
|
23
+11%
|
38
+62%
|
16
-59%
|
169
+978%
|
227
+35%
|
318
+40%
|
232
-27%
|
350
+51%
|
506
+44%
|
|
| Total Liabilities & Equity |
88
N/A
|
78
-12%
|
79
+2%
|
170
+115%
|
182
+7%
|
309
+70%
|
493
+60%
|
613
+24%
|
539
-12%
|
660
+22%
|
779
+18%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
6
|
6
|
6
|
6
|
6
|
9
|
15
|
15
|
15
|
15
|
15
|
|
Switch to:
Switch to:
See Also
Discover More
